267 related articles for article (PubMed ID: 27129281)
1. Modulation of P2X3 and P2X2/3 Receptors by Monoclonal Antibodies.
Shcherbatko A; Foletti D; Poulsen K; Strop P; Zhu G; Hasa-Moreno A; Melton Witt J; Loo C; Krimm S; Pios A; Yu J; Brown C; Lee JK; Stroud R; Rajpal A; Shelton D
J Biol Chem; 2016 Jun; 291(23):12254-70. PubMed ID: 27129281
[TBL] [Abstract][Full Text] [Related]
2. Flexible subunit stoichiometry of functional human P2X2/3 heteromeric receptors.
Kowalski M; Hausmann R; Schmid J; Dopychai A; Stephan G; Tang Y; Schmalzing G; Illes P; Rubini P
Neuropharmacology; 2015 Dec; 99():115-30. PubMed ID: 26184350
[TBL] [Abstract][Full Text] [Related]
3. BLU-5937: A selective P2X3 antagonist with potent anti-tussive effect and no taste alteration.
Garceau D; Chauret N
Pulm Pharmacol Ther; 2019 Jun; 56():56-62. PubMed ID: 30902655
[TBL] [Abstract][Full Text] [Related]
4. Subtype-specific control of P2X receptor channel signaling by ATP and Mg2+.
Li M; Silberberg SD; Swartz KJ
Proc Natl Acad Sci U S A; 2013 Sep; 110(36):E3455-63. PubMed ID: 23959888
[TBL] [Abstract][Full Text] [Related]
5. Action of MK-7264 (gefapixant) at human P2X3 and P2X2/3 receptors and in vivo efficacy in models of sensitisation.
Richards D; Gever JR; Ford AP; Fountain SJ
Br J Pharmacol; 2019 Jul; 176(13):2279-2291. PubMed ID: 30927255
[TBL] [Abstract][Full Text] [Related]
6. P2X3 and P2X2/3 receptors mediate mechanical hyperalgesia induced by bradykinin, but not by pro-inflammatory cytokines, PGE₂ or dopamine.
de Oliveira Fusaro MC; Pelegrini-da-Silva A; Araldi D; Parada CA; Tambeli CH
Eur J Pharmacol; 2010 Dec; 649(1-3):177-82. PubMed ID: 20868656
[TBL] [Abstract][Full Text] [Related]
7. P2X3 and P2X2/3 Receptors Play a Crucial Role in Articular Hyperalgesia Development Through Inflammatory Mechanisms in the Knee Joint Experimental Synovitis.
Teixeira JM; Bobinski F; Parada CA; Sluka KA; Tambeli CH
Mol Neurobiol; 2017 Oct; 54(8):6174-6186. PubMed ID: 27709491
[TBL] [Abstract][Full Text] [Related]
8. Identification of aurintricarboxylic acid as a potent allosteric antagonist of P2X1 and P2X3 receptors.
Obrecht AS; Urban N; Schaefer M; Röse A; Kless A; Meents JE; Lampert A; Abdelrahman A; Müller CE; Schmalzing G; Hausmann R
Neuropharmacology; 2019 Nov; 158():107749. PubMed ID: 31461640
[TBL] [Abstract][Full Text] [Related]
9. Update on novel purinergic P2X3 and P2X2/3 receptor antagonists and their potential therapeutic applications.
Marucci G; Dal Ben D; Buccioni M; Martí Navia A; Spinaci A; Volpini R; Lambertucci C
Expert Opin Ther Pat; 2019 Dec; 29(12):943-963. PubMed ID: 31726893
[No Abstract] [Full Text] [Related]
10. Selective potentiation of homomeric P2X2 ionotropic ATP receptors by a fast non-genomic action of progesterone.
De Roo M; Boué-Grabot E; Schlichter R
Neuropharmacology; 2010 Mar; 58(3):569-77. PubMed ID: 20004677
[TBL] [Abstract][Full Text] [Related]
11. Characterization of cultured dorsal root ganglion neuron P2X receptors.
Grubb BD; Evans RJ
Eur J Neurosci; 1999 Jan; 11(1):149-54. PubMed ID: 9987019
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous firing and evoked responses of spinal nociceptive neurons are attenuated by blockade of P2X3 and P2X2/3 receptors in inflamed rats.
Xu J; Chu KL; Brederson JD; Jarvis MF; McGaraughty S
J Neurosci Res; 2012 Aug; 90(8):1597-606. PubMed ID: 22422599
[TBL] [Abstract][Full Text] [Related]
13. P2X3 receptors mediate visceral hypersensitivity during acute chemically-induced colitis and in the post-inflammatory phase via different mechanisms of sensitization.
Deiteren A; van der Linden L; de Wit A; Ceuleers H; Buckinx R; Timmermans JP; Moreels TG; Pelckmans PA; De Man JG; De Winter BY
PLoS One; 2015; 10(4):e0123810. PubMed ID: 25885345
[TBL] [Abstract][Full Text] [Related]
14. Endogenous opioid mechanisms partially mediate P2X3/P2X2/3-related antinociception in rat models of inflammatory and chemogenic pain but not neuropathic pain.
McGaraughty S; Honore P; Wismer CT; Mikusa J; Zhu CZ; McDonald HA; Bianchi B; Faltynek CR; Jarvis MF
Br J Pharmacol; 2005 Sep; 146(2):180-8. PubMed ID: 16041397
[TBL] [Abstract][Full Text] [Related]
15. Subtype-specific regulation of P2X3 and P2X2/3 receptors by phosphoinositides in peripheral nociceptors.
Mo G; Bernier LP; Zhao Q; Chabot-Doré AJ; Ase AR; Logothetis D; Cao CQ; Séguéla P
Mol Pain; 2009 Aug; 5():47. PubMed ID: 19671169
[TBL] [Abstract][Full Text] [Related]
16. Stable, synthetic analogs of diadenosine tetraphosphate inhibit rat and human P2X3 receptors and inflammatory pain.
Viatchenko-Karpinski V; Novosolova N; Ishchenko Y; Azhar MA; Wright M; Tsintsadze V; Kamal A; Burnashev N; Miller AD; Voitenko N; Giniatullin R; Lozovaya N
Mol Pain; 2016; 12():. PubMed ID: 27030723
[TBL] [Abstract][Full Text] [Related]
17. P2X3 and P2X2/3 receptors activation induces articular hyperalgesia by an indirect sensitization of the primary afferent nociceptor in the rats' knee joint.
Teixeira JM; Parada CA; Tambeli CH
Eur J Pharmacol; 2020 Jul; 879():173054. PubMed ID: 32145326
[TBL] [Abstract][Full Text] [Related]
18. A hydrophobic residue in position 15 of the rP2X3 receptor slows desensitization and reveals properties beneficial for pharmacological analysis and high-throughput screening.
Hausmann R; Bahrenberg G; Kuhlmann D; Schumacher M; Braam U; Bieler D; Schlusche I; Schmalzing G
Neuropharmacology; 2014 Apr; 79():603-15. PubMed ID: 24452010
[TBL] [Abstract][Full Text] [Related]
19. A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat.
Jarvis MF; Burgard EC; McGaraughty S; Honore P; Lynch K; Brennan TJ; Subieta A; Van Biesen T; Cartmell J; Bianchi B; Niforatos W; Kage K; Yu H; Mikusa J; Wismer CT; Zhu CZ; Chu K; Lee CH; Stewart AO; Polakowski J; Cox BF; Kowaluk E; Williams M; Sullivan J; Faltynek C
Proc Natl Acad Sci U S A; 2002 Dec; 99(26):17179-84. PubMed ID: 12482951
[TBL] [Abstract][Full Text] [Related]
20. Control of P2X3 channel function by metabotropic P2Y2 utp receptors in primary sensory neurons.
Mo G; Peleshok JC; Cao CQ; Ribeiro-da-Silva A; Séguéla P
Mol Pharmacol; 2013 Mar; 83(3):640-7. PubMed ID: 23249537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
